Not applicableUnknownNCT01099852What this trial is testingCohort of Patients Infected by an ArbovirusWho this might be right forFeverDengueChikungunya+1 more University Hospital Center of Martinique 1,377
Testing effectiveness (Phase 2)Study completedNCT01187433What this trial is testingStudy of CYD Dengue Vaccine in Healthy Children and Adolescents in South AmericaWho this might be right forDengueDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 150
Large-scale testing (Phase 3)Study completedNCT02993757What this trial is testingImmunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®Who this might be right forDengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease Sanofi Pasteur, a Sanofi Company 528
Testing effectiveness (Phase 2)Study completedNCT00993447What this trial is testingImmunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin AmericaWho this might be right forDengueDengue Hemorrhagic FeverDengue Virus+1 more Sanofi Pasteur, a Sanofi Company 600
Testing effectiveness (Phase 2)Study completedNCT02824198What this trial is testingImmunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose ScheduleWho this might be right forDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 118
Testing effectiveness (Phase 2)UnknownNCT06071481What this trial is testingRole of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock SyndromeWho this might be right forDengue Fever Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 120
Not applicableActive Not RecruitingNCT06642493What this trial is testingEfficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue PatientsWho this might be right forDengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome Sheikh Hasina National Institute of Burn and Plastic Surgery 300
Testing effectiveness (Phase 2)Study completedNCT01488890What this trial is testingImmune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever+1 more Sanofi Pasteur, a Sanofi Company 390
Testing effectiveness (Phase 2)Study completedNCT00788151What this trial is testingStudy of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsWho this might be right forDengue VirusDengue FeverDengue Hemorrhagic Fever+1 more Sanofi Pasteur, a Sanofi Company 300
Early research (Phase 1)Study completedNCT01072786What this trial is testingEvaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus VaccineWho this might be right forDengue National Institute of Allergy and Infectious Diseases (NIAID) 141
Early research (Phase 1)Study completedNCT01073306What this trial is testingSafety and Immune Response to an Investigational Dengue Type 2 VaccineWho this might be right forDengue Virus National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00842530What this trial is testingEfficacy and Safety of Dengue Vaccine in Healthy ChildrenWho this might be right forDengue VirusDengue FeverDengue Hemorrhagic Fever+1 more Sanofi Pasteur, a Sanofi Company 4,002
Early research (Phase 1)Study completedNCT00270699What this trial is testingSafety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy AdultsWho this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT00730288What this trial is testingStudy of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever+1 more Sanofi 35
Early research (Phase 1)Study completedNCT01436422What this trial is testingEvaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineWho this might be right forDengue National Institute of Allergy and Infectious Diseases (NIAID) 112
Testing effectiveness (Phase 2)Study completedNCT02741128What this trial is testingSafety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsWho this might be right forDengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus Sanofi Pasteur, a Sanofi Company 133
Not applicableStudy completedNCT01477671What this trial is testingProspective Dengue Seroprevalence Study in 5 to 10 Year-old ChildrenWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 667
Early research (Phase 1)Study completedNCT00094705What this trial is testingSafety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy AdultsWho this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT02392325What this trial is testingEvaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy AdultsWho this might be right forDengue National Institute of Allergy and Infectious Diseases (NIAID) 12
Testing effectiveness (Phase 2)Study completedNCT03432442What this trial is testingPharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue PatientsWho this might be right forDengue Hemorrhagic Fever Mahidol University 24